• PCR110 Valuation of Child Health: A United States Value Set for the EQ-5D-Y-3L

    Jun 1, 2024, 00:00

  • Patient Impact of Rare Diseases

    Jun 1, 2024, 00:00

  • EE297 Pricing Strategies and Trends of FDA Approved NSCLC Therapies From 2018 to 2023

    Jun 1, 2024, 00:00

  • PCR154 Health State Utility Values in COVID-19: A Vignette Study in Japan

    Jun 1, 2024, 00:00

  • SA55 Efficacy and Tolerability of Contingency Management and Cognitive-Behavioral Therapy With Pharmacotherapy or Placebo in Managing Stimulant Use Disorder: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • EE271 Lifetime Productivity Loss Due to HIV Mortality in the United States

    Jun 1, 2024, 00:00

  • PCR121 Optimizing Drug Value and Access Using Implementation Science

    Jun 1, 2024, 00:00

  • EE318 Reduction of Costs Associated With the Use of Emicizumab in Prophylaxis in Pediatric Patients Diagnosed With Severe Hemophilia A and Inhibitors in El Salvador

    Jun 1, 2024, 00:00

  • MSR15 Revolutionizing Systematic Literature Reviews: Harnessing the Power of Large Language Model (GPT-4) for Enhanced Research Synthesis

    Jun 1, 2024, 00:00

  • EPH150 Post-Market Safety Assessment Associated with JAK Inhibitors of Xeljanz, Olumiant, and Rinvoq Using Faers Database from 2012 to 2022

    Jun 1, 2024, 00:00

  • EE107 Long-Term Cost-Effectiveness of iGlarLixi Versus IDegLira in Patients With Uncontrolled Type 2 Diabetes Treated With Basal Insulin or Oral Antidiabetic Drug in China

    Jun 1, 2024, 00:00

  • EE341 A Comparison of Stapling Costs Used in Hybrid vs Robotic Surgery

    Jun 1, 2024, 00:00

  • HPR128 Benchmarking Clinical Trial Diversity: Methods to Characterize Eligibility-Based Representativeness

    Jun 1, 2024, 00:00

  • CO80 Using Machine Learning to Understand Predictors of Frequent Surveillance Testing in Colorectal Cancer Patients

    Jun 1, 2024, 00:00

  • P30 Semi-Markov Model (sMM) Versus Trial-Level Surrogacy to Predict Overall Survival (OS) for Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma (MIUC) with Chemotherapy

    Jun 1, 2024, 00:00

  • EPH81 Patient Characteristics and Health Care Resource Utilization of Cognitive Impairment Among Patients with Schizophrenia in the Veterans Affairs Administration System

    Jun 1, 2024, 00:00

  • CO148 The Impact of Approved Anti-Obesity Medications on Osteoarthritis Risk in Patients With Obesity: A Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • HTA47 Assessing the Effectiveness and Cost of Future Technologies to Screen for Colorectal Cancer

    Jun 1, 2024, 00:00

  • EE295 Economic Burden Associated With Managing Patients With Sickle Cell Disease Receiving Frequent Red Blood Cell Transfusions in the United States

    Jun 1, 2024, 00:00

  • EE415 Cost of Hypoglycemia Among Hospitalized Patients With Diabetes Mellitus

    Jun 1, 2024, 00:00

  • PCR178 Use of Patient Reported Outcomes in Registered Drug Studies for Long COVID

    Jun 1, 2024, 00:00

  • SA33 Real-World Comparison of Adherence and Persistence between Glucagon-like Peptide-1 Receptor Agonist (GLP-1) and Sodium-Glucose Cotransporter 2 (SGLT-2) in Patients with Type 2 Diabetes (T2D)

    Jun 1, 2024, 00:00

  • HSD74 COVID-19's Impact on Healthcare Access for Arthritis Patients: Insights From the 2020 Medical Expenditure Panel Survey

    Jun 1, 2024, 00:00

  • RWD117 Unraveling Disparities in Right Heart Failure: A Comprehensive Analysis of Demographics, Socioeconomic Factors, and Mortality Predictors in a 117,633-Patient Cohort (2017-2020)

    Jun 1, 2024, 00:00

  • EPH204 Chronic Liver Disease Is Associated with Greater Risk of Hospital Readmission in Patients with Heart Failure: A Nationwide Database Study in the US

    Jun 1, 2024, 00:00

  • HTA81 Assessing Evidence Packages of CRISPR Technologies: Will They Meet Payer Needs?

    Jun 1, 2024, 00:00

  • CO115 Long-Term Post-Recurrence Survival (PRS) Outcomes for Stage IIB/C Melanoma Patients in Real-World (RW) Settings: Analyses from a Longitudinal Electronic Health Record Database in the United States

    Jun 1, 2024, 00:00

  • EPH44 Healthcare Expenditures Among Older Adult with Polypharmacy in the United States: A Propensity Score-Matched Cross-Sectional Study

    Jun 1, 2024, 00:00

  • CO54 Timely Rheumatoid Arthritis Control With Biologic or Targeted Synthetic DMARDs in Clinical Practi Separating Successes From Opportunities for Care Improvement

    Jun 1, 2024, 00:00

  • HPR55 Limiting the Potency of Delta-9-Tetrahydrocannabinol (THC) in Cannabis Products: What Policymakers Need to Know

    Jun 1, 2024, 00:00

  • EE333 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the U.S.: An Updated Analysis

    Jun 1, 2024, 00:00

  • CO153 Predicting Overall Survival (OS) Benefit in Previously Untreated Metastatic Melanoma From Improvements in Response Outcomes: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)

    Jun 1, 2024, 00:00

  • RWD68 The TriNetX Linked EHR and Administrative Claims Network

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • RWD3 Review of the Use of Electronic Health Records for Advancing Schizophrenia Research in the UK

    Jun 1, 2024, 00:00

  • EE376 The Budget Impact of Introducing Multiparametric MRI (mpMRI) As a Monitoring Tool to Identify Non-Responders Undergoing Thyroid Hormone Receptor Treatment for MASH

    Jun 1, 2024, 00:00

  • EE474 Value Assessment Under Uncertainty: Measuring Insurance Value and Risk Aversion for a Novel Neurological Treatment Using a Stated Preference Survey

    Jun 1, 2024, 00:00

  • EE188 Decision Model to Evaluate the Cost of Clinical Events Associated with Switching from Apixaban to Rivaroxaban Among Patients with Non-Valvular Atrial Fibrillation in the United States

    Jun 1, 2024, 00:00

  • EE307 Economic Evaluation of a Screening Programme for Diabetes, Hypertension and Hyperlipidaemia in Middle-Aged Adults in Hong Kong: A Simulation Analysis

    Jun 1, 2024, 00:00

  • Methodological Statistical Research

    Jun 1, 2024, 00:00

  • PCR166 Real-World Discontinuation of High-Efficacy Disease Modifying Therapies for the Treatment of Multiple Sclerosis: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • EPH112 Prevalent Comorbidities and Disease-Related Conditions in Heavily Pre-Treated Patients With Multiple Myeloma: A Real-World Retrospective Database Analysis

    Jun 1, 2024, 00:00

  • MT36 Assessment and Comparison of the Manual Steps Required to Perform Whole Blood Processing Using a Semi-Automated Method Versus a Fully Automated Method

    Jun 1, 2024, 00:00

  • EPH213 Burden of Heart Failure After Hospitalization for Myocardial Infarction in the United States: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • RWD25 Trends and Utilization of Open, Laparoscopic, and Robotic-Assisted Appendectomy: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • PT38 Early and Mid-Term Outcome of Valve Replacement With Porcine Bioprosthesis in the Aortic Positions

    Jun 1, 2024, 00:00

  • EE164 A Systematic Review and Meta-Analysis of Economic Burden of Breast Cancer Among Adult Females: Based on the Perspective of Social Development Level and Progression of Disease

    Jun 1, 2024, 00:00

  • PCR188 Compliance and Design Features of Electronic Participant-Reported Dosing Diaries

    Jun 1, 2024, 00:00

  • HSD22 Extending External Validity of Rcts and Meta-Analysis through Transportability Analysis and Integration of Mechanistic Research Evidence

    Jun 1, 2024, 00:00

  • EE386 Restoration of Endodontically Treated Teeth: A Cost-Effectiveness Analysis of Endocrown Versus Complete Crown

    Jun 1, 2024, 00:00

  • MSR58 Comparing Predictive Models: Traditional Versus Modern Statistical Approaches for Economic Outcomes in Major Depressive Disorder

    Jun 1, 2024, 00:00

  • SA24 CHIME2 (Chinese Hong Kong Integrated Modeling and Evaluation): An Updated Model to Simulate Lifetime Health Outcomes of Patients with Type 2 Diabetes

    Jun 1, 2024, 00:00

  • RWD178 Costs of Cancer Care Across the Disease Continuum: An Analysis From a Health Payer Perspective in Brazil

    Jun 1, 2024, 00:00

  • EE101 Estimating the Burden of Osteogenesis Imperfecta on Patients and Healthcare Payers: A Health Economic Modelling Study

    Jun 1, 2024, 00:00

  • RWD183 Experience in Implementing Clinical Trial to Real-World Data (RWD) Linkage

    Jun 1, 2024, 00:00

  • HSD121 Real-World Prescribing of Tirzepatide Labeled for Obesity in the United States

    Jun 1, 2024, 00:00

  • EE278 Cost-Effectiveness Analysis of Premature Infant Oral Motor Intervention (PIOMI) in the Neonatal Intensive Care Unit in Colombia, 2022

    Jun 1, 2024, 00:00

  • EE350 Cost-Effectiveness Analysis of Xigduo (EXTENDED-RELEASE DAPAGLIFLOZIN-METFORMIN TABLETS) for Managing Type 2 Diabetes Mellitus (T2DM) Patients

    Jun 1, 2024, 00:00

  • CO13 A Claims Analysis To Characterize All-Cause Mortality in Patients With Generalized Pustular Psoriasis in the United States

    Jun 1, 2024, 00:00

  • MSR64 Using Large Language Models To Extract PD-L1 Testing Details From Electronic Health Records

    Jun 1, 2024, 00:00

  • RWD40 Concomitant Use of Opioids and Psychotropic Medications in Mississippi Medicaid Beneficiaries

    Jun 1, 2024, 00:00

  • RWD182 AI-Assisted Chart Review to Understand Disease Flares in Systemic Lupus Erythematosus

    Jun 1, 2024, 00:00

  • EE87 Time-Driven Activity Based Costing of Advanced Ovarian Cancer From the Perspective of a Brazilian Public Hospital

    Jun 1, 2024, 00:00

  • CO144 Association of All-Cause and Cause-Specific Mortality with High-Risk NAFLD/NASH in US Adults, NHANES III (1988-1994) Linked to Mortality Data through 2019

    Jun 1, 2024, 00:00

  • P48 Automating Economic Modelling: Potential of Generative AI for Updating Excel-Based Cost-Effectiveness Models

    Jun 1, 2024, 00:00

  • EE142 A Cost Utility Analysis of Zuranolone in the Treatment of Major Depressive Disorder

    Jun 1, 2024, 00:00

  • CO41 Comparative Effectiveness of Glucagon-like Peptide 1 Agonists Vs Dipeptidyl Peptidase 4 Inhibitors on Liver Outcomes in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Fatty Liver Disease

    Jun 1, 2024, 00:00

  • MSR61 Perceptions of the Feasibility of AI-Based Machine Translation for Linguistic Validation

    Jun 1, 2024, 00:00

  • HPR150 Beyond the Headline: Inflation-Adjusting ICER's Unsupported Price Increase Results

    Jun 1, 2024, 00:00

  • EE129 Tools for the Critical Appraisal of Health Economic Analyses: A Scoping Review

    Jun 1, 2024, 00:00

  • PCR49 Mapping and Linking between the EQ-5D-5L and the PROPr in the United States

    Jun 1, 2024, 00:00

  • EPH119 Public Health Results in the Department of Bolívar, Colombia: An Analysis of Indicators in 2023

    Jun 1, 2024, 00:00

  • HTA13 Survey Data in Value Demonstration: Acceptability within Health Technology Assessments in the UK

    Jun 1, 2024, 00:00

  • EPH94 Healthcare Access and Health Equity Outcomes Among Adults With Cardiometabolic Conditions

    Jun 1, 2024, 00:00

  • EE528 Comparative Effectiveness Modeling of an Anti-Pd-1 Antibody Drug Intervention for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in the U.S.

    Jun 1, 2024, 00:00

  • CO206 The Clinical and Financial Impact of Sustained Annual Wellness Visit Engagement in the Blue Cross and Blue Shield of Louisiana Medicare Advantage Population

    Jun 1, 2024, 00:00

  • HSD55 Real-World Medication Management of Adults With Sickle Cell Disease in the United States

    Jun 1, 2024, 00:00

  • HPR75 Can Multi-Cancer Early Detection Screening Result in Early Cancer Detection? A Modeling Study

    Jun 1, 2024, 00:00

  • EPH19 Opioid-Related Overdose Death Rates in the US From 2005 to 2021

    Jun 1, 2024, 00:00

  • EE328 Direct Medical Costs in Patients with Non-Metastatic Castration Resistant Prostate Cancer (nmCRPC) in Colombia

    Jun 1, 2024, 00:00

  • P2 Economic Burden and Healthcare Resource Utilization in Sjögren's Disease: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EE332 Cost-Effectiveness Analysis of Implementing a Field Hospital during a Pandemic

    Jun 1, 2024, 00:00

  • PT20 Gleaning Novel Insights from Real World Data: A Machine-Learning Guided Analytical Framework

    Jun 1, 2024, 00:00

  • EE153 Cost-Minimization of Oral Valganciclovir Vs Intravenous Ganciclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients

    Jun 1, 2024, 00:00

  • SA77 Race and Ethnicity in Oracle EHR Real-World Data: A Contrast to Self-Reported Data in the United States

    Jun 1, 2024, 00:00

  • EPH160 A Risk Stratification Analysis of ASCVD Events Post-Statin Discontinuation in Bariatric Surgery Patients

    Jun 1, 2024, 00:00

  • HTA76 Insights into Health Technology Reassessment in Fran A Comprehensive Analysis of Key Outcomes and Manufacturers Engagement (2022-2023)

    Jun 1, 2024, 00:00

  • CO50 Benefit and Risk of Oral Anticoagulant Initiation Strategies in Patients With Atrial Fibrillation and Cancer: A Target Trial Emulation Using the SEER-Medicare Database

    Jun 1, 2024, 00:00

  • HTA33 Lung Cancer Health Technology Assessments Trends in Argentina, Brazil, Colombia, and Mexico

    Jun 1, 2024, 00:00

  • Health Equity Considerations in Economic Evaluations

    Jun 1, 2024, 00:00

  • MSR52 Assessing the Representativeness of Provider Encounter Data From a Large Claims Database on Adults With Major Depression

    Jun 1, 2024, 00:00

  • MSR14 Multi-Output Learning for Rare Event Analysis

    Jun 1, 2024, 00:00

  • OP10 The Meteoric Rise of RWE and HEOR: Operating With Efficiency and Fostering Innovation Between the Two Groups

    Jun 1, 2024, 00:00

  • EE435 Hospitalization Costs of Common Grade 3/4 Adverse Events Associated With Oncology Treatments in the United States

    Jun 1, 2024, 00:00

  • HSD31 Analyzing Factors Affecting Length of Emergency Department Stay in Patients With Hemophilia

    Jun 1, 2024, 00:00

  • PCR50 Estimating Meaningful Change Thresholds (MCTs) for EORTC Scales in a Phase 3 Trial in Participants With Inoperable or Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

    Jun 1, 2024, 00:00

  • PCR39 Exploring Patient and Caregiver Perspectives on Burden Associated with Friedreich Ataxia in the USA

    Jun 1, 2024, 00:00

  • EE260 Economic Analysis of a Low-Threshold Mobile Medical Unit Dispensing Buprenorphine for Opioid Use Disorder

    Jun 1, 2024, 00:00

  • HPR77 CMS Coverage Lift on PET Beta Amyloid Imaging Impact on mAb Treatment and Beneficiary Out-Of-Pocket Spending

    Jun 1, 2024, 00:00

  • RWD53 An Inflection Point in Real-World Treatment Intensification for Men With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in the United States (US): Results From Patient Chart Reviews

    Jun 1, 2024, 00:00

  • EE77 Non-Quality Costs of Unsafe Healthcare in a Hospital Institution

    Jun 1, 2024, 00:00

  • HPR127 Examine the Use of Real-World Evidence To Support FDA Decision-Making for New Drug Applications and Biologics License Applications From 2021 to 2022

    Jun 1, 2024, 00:00

  • MSR18 Improving the Performance of Generative AI to Achieve 100% Accuracy in Data Extraction

    Jun 1, 2024, 00:00

  • HPR129 Real-World Policy Effects of Implementing Multi-Gene Panel Sequencing for Advanced Cancers in British Columbia, Canada: An Interrupted Time Series Analysis

    Jun 1, 2024, 00:00

  • HTA30 Evolution of Health Technology Assessment for Rare Diseases and Its Impact on Access

    Jun 1, 2024, 00:00

  • P15 A Review of Methods and Guidance for Considering Equity in Health Economic Research

    Jun 1, 2024, 00:00

  • EE419 The Economic Burden of Thyroid Eye Disease in the Kingdom of Saudi Arabia

    Jun 1, 2024, 00:00

  • EE353 An Analysis of Stakeholders’ Contribution to High-WAC and Low-WAC Adalimumab Products in 2025 Under the Inflation Reduction Act in the United States

    Jun 1, 2024, 00:00

  • EE449 Cost-Effectiveness Thresholds Around the World: How Brazil Positions Itself Compared to Other Countries

    Jun 1, 2024, 00:00

  • CO32 Predictors of Overall Survival (OS) and Time to Next Treatment (TTNT) in Real-World Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) Patients Who Received First-Line (1L) Folfirinox (FFX) or Gemcitabine + Nab-paclitaxel (GnP)

    Jun 1, 2024, 00:00

  • P22 Measuring Health-Related Quality of Life during Pregnancy: Exploring the Psychometric Properties of PROMIS to Assess Health-Related Quality of Life

    Jun 1, 2024, 00:00

  • P7 Costs and Health Care Resource Utilization Associated with Negative Symptoms Among Patients with Schizophrenia in the United States

    Jun 1, 2024, 00:00

  • HSD77 Prescription Patterns for COVID-19 before the Availability of Antiviral Drugs Using the National Database of Health Insurance Claims in Japan

    Jun 1, 2024, 00:00

  • EE311 Exploring Environmental Impacts of Switching Salmeterol/Fluticasone Propionate (SAL/FP) from Metered Dose Inhaler (MDI) to Dry Powder Inhaler (DPI) in Respiratory Illness in the United Kingdom

    Jun 1, 2024, 00:00

  • SA35 Assessing Meta-Analyses and Systematic Literature Reviews Comparing Effectiveness of Treatments for Relapsed/Refractory Multiple Myeloma (RRMM): A Targeted Literature Review From 2017-2023

    Jun 1, 2024, 00:00

  • RWD157 Objective Fit-4-Purpose Assessment of Real-World Data for Evidence Generation in Type 2 Diabetes Mellitus: A Trial Tokenization Approach

    Jun 1, 2024, 00:00

  • EE390 Economic Evaluation and Healthcare Resource Utilization (HCRU) Among Breast Cancer Patients Treated with Palbociclib: A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • OP3 The Upgrade of Educational System for Improving Practical Skills of Economics Graduate Students in HTA in Ukraine

    Jun 1, 2024, 00:00

  • HSD85 The Power of Click on Pharma Consumer: Navigating the Evolution and Challenges of Drug E-Commerce

    Jun 1, 2024, 00:00

  • CO3 Prediction of Long-Term Factor IX Durability Among Hemophilia B Patients Treated with Fidanacogene Elaparvovec Gene Therapy

    Jun 1, 2024, 00:00

  • CO133 A Propensity Score Matched Analysis Between an Infrarenal Fixation Device With ePTFE (Device A) and Two Suprarenal Fixation Devices With Dacron Fabric (Devices B and C)

    Jun 1, 2024, 00:00

  • PCR205 Qualitative Analysis of Twitter Data on Attitudes of Men Who Have Sex with Men Related to Long Acting Injectable Prep

    Jun 1, 2024, 00:00

  • HSD65 Influence of Research Findings and Systems on Minimal Residual Disease (MRD) Testing and FLT3 Inhibitor Maintenance Prescribing Behavior Post-Transplant for Patients with Acute Myeloid Leukemia (AML) of U.S. Oncologists

    Jun 1, 2024, 00:00

  • Advancing the Use of Patient Reported Outcomes

    Jun 1, 2024, 00:00

  • EE516 Estimating the Benefits of Reduced Fracture Incidence for Patients Living with Osteogenesis Imperfecta and for Healthcare Payers

    Jun 1, 2024, 00:00

  • HPR138 A Non-Representative Sample: Racial and Ethnic Diversity in Clinical Trials of FDA-Approved Drugs

    Jun 1, 2024, 00:00

  • HPR3 Exploring the Inequity of HRQoL in Individuals With Long COVID Symptoms

    Jun 1, 2024, 00:00

  • HTA28 Comparative Analysis of Orphan Drug HTA Assessment: Perspectives from HAS and SMC

    Jun 1, 2024, 00:00

  • EE394 Redefining the Scope: The Urgent Need for Holistic Multiple Sclerosis Modeling in Health Economics

    Jun 1, 2024, 00:00

  • CO16 Shared Identity and Patient Care: Examining Racial and Gender Concordance on Treatment and Testing Adherence in CML

    Jun 1, 2024, 00:00

  • CO107 Assessing Short and Long-Term Outcomes in Drug-Associated Acute Kidney Injury

    Jun 1, 2024, 00:00

  • EPH147 Socioeconomic Burden of Ischemic Heart Diseases in the Japanese Healthcare System – A System Dynamics Simulation for Policy Decision-Making

    Jun 1, 2024, 00:00

  • MT35 Budget Impact Analysis of a Digital Intervention for Disease Management in Type 2 Diabetes

    Jun 1, 2024, 00:00

  • RWD51 The Added Value of Linking Real-World Data Sources

    Jun 1, 2024, 00:00

  • CO95 Growing Acceptance of Minimal Residual Disease (MRD) As a Primary Endpoint in Multiple Myeloma (MM) Clinical Trials

    Jun 1, 2024, 00:00

  • RWD96 Risk of Venous Thromboembolism with Janus Kinase Inhibitors in Rheumatoid Arthritis: A Systematic Review

    Jun 1, 2024, 00:00

  • RWD10 Annual Health Insurance Treatment Cost of Female Infertility of Another Origin Based on Routinely Collected Financing Data between 2010-2019

    Jun 1, 2024, 00:00

  • EPH230 County-Level Social Vulnerability Is Associated With Lower Pneumococcal Vaccine Uptake Among Medicare Beneficiaries in the United States (2016-2019)

    Jun 1, 2024, 00:00

  • EE266 The Economics Promises of a Cure: Best Practices to Guide Economic Negotiations for the Reimbursement of Curative Therapies for Cancer

    Jun 1, 2024, 00:00

  • CO81 Cyclosporine Ophthalmic Solution 0.09% Improves the Signs and Symptoms of Dry Eye Disease in Patients Whose Disease Is Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%

    Jun 1, 2024, 00:00

  • EE526 Predictors of Annual Eyewear Expenditures in the United States

    Jun 1, 2024, 00:00

  • EPH187 Examinating the Safety of Recently Approved Drugs for Cardiovascular Disease Using A Large Database

    Jun 1, 2024, 00:00

  • MSR84 Understanding How Baseline Risk Affects Treatment Outcomes in Clinical Trials: Exploring Key Factors

    Jun 1, 2024, 00:00

  • Clinical Outcomes

    Jun 1, 2024, 00:00

  • HTA29 Improving Patient Access to New Health Interventions: Introduction of HTA for Medical Devices in Ukraine According to the Roadmap

    Jun 1, 2024, 00:00

  • P32 Effective Data Visualization Techniques for Presenting Scenario Analysis Results in Health Economic Models

    Jun 1, 2024, 00:00

  • CO197 Vaso-Occlusion Definitions Can Impact Efficacy Assessments in Clinical Studies of Sickle Cell Disease

    Jun 1, 2024, 00:00

  • MSR35 Item Performance and Structural Validity of the Quick Motor Function Test Among Late Onset Pompe Disease Patients

    Jun 1, 2024, 00:00

  • EE235 Health Care Related Costs of Treatment Delay Among Medicare Beneficiaries Diagnosed With Colon Cancer

    Jun 1, 2024, 00:00

  • RWD125 Evaluation of the Case-Mix-Index of Hungarian One-Day Surgical Treatment

    Jun 1, 2024, 00:00

  • HSD128 Opioid Utilization in Rheumatoid Arthritis: Changes in Opioid Use after Advanced Therapy Initiation and Its Moderators

    Jun 1, 2024, 00:00

  • EE369 Healthcare Resource Utilization Among Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in Canada

    Jun 1, 2024, 00:00

  • HTA65 How Does Conditional Regulatory Approval Affect the Reimbursement of Drugs in Canada?

    Jun 1, 2024, 00:00

  • EPH50 Characterizing the Prevalence of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Among Adults ≥65 Years of Age in the United States (US) Using Three Real-World Cohorts

    Jun 1, 2024, 00:00

  • PCR201 Understanding the Patient Experience With High Cholesterol in the United States: A Patient-Community-Led Qualitative Study

    Jun 1, 2024, 00:00

  • P60 Evaluating Dynamic Treatment Using a Target Trial: The Real-World Effectiveness of Adding Oral Selexipag to a Double Oral Therapy for the Treatment of Patients With Pulmonary Arterial Hypertension

    Jun 1, 2024, 00:00

  • EPH86 Association of Long-COVID with Depression Among Adults in the United States

    Jun 1, 2024, 00:00

  • P46 Can Large Language Models Simulate HTA Committee Discussions? Findings and Challenges from a Case Study in Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer

    Jun 1, 2024, 00:00

  • RWD67 Influenza's Impact on Heart Failure Patients: A Ten-Year Analysis

    Jun 1, 2024, 00:00

  • CO146 Treatment Use and Overall Survival of Patients with Unresectable/Metastatic Melanoma in Colombia: A Real World Study

    Jun 1, 2024, 00:00

  • RWD115 Is More Always Better? a Real-World Data Analysis of Hemoglobin A1C Data in Patients with Diabetes

    Jun 1, 2024, 00:00

  • PCR91 Patient Perspectives on Treatment Effectiveness in Psoriatic Arthritis: A Pilot Qualitative Study to Understand What Matters Most

    Jun 1, 2024, 00:00

  • EE458 Economic Burden of Disease Recurrence in Elderly Patients With Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Early Breast Cancer (eBC)

    Jun 1, 2024, 00:00

  • EE514 Private Hospital Acute Stroke Care Costs: Patient's Viewpoint

    Jun 1, 2024, 00:00

  • EPH138 Pneumococcal Vaccine Trends Among Older Adults in the United States from 2008 to 2022

    Jun 1, 2024, 00:00

  • PT21 A Generalized Framework for Eliciting Unreported Subgroup-Specific Events and Survival Outcomes from Aggregate Level Data: Analyses Advanced Stage Gastrointestinal Cancers

    Jun 1, 2024, 00:00

  • HSD104 Semaglutide and Tirzepatide in Type 2 Diabetes: Patient Characteristics and Weight-Related Outcomes in the Real-World Setting

    Jun 1, 2024, 00:00

  • EPH149 Regional Dynamics and Prevalence of COVID-19 Variants in US Health and Human Services Regions

    Jun 1, 2024, 00:00

  • PCR77 Postoperative Utilization of Other Orthopedic Services Adversely Affects Patient Reported Outcomes After Total Hip Arthroplasty

    Jun 1, 2024, 00:00

  • HTA37 Digital Health Value Assessment Frameworks: An International Landscape

    Jun 1, 2024, 00:00

  • SA11 Real-World Effectiveness and Safety of First-Line Pembrolizumab Monotherapy for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • SA72 Health System As an Adaptative Complex System for Open Innovation

    Jun 1, 2024, 00:00

  • RWD35 Assessing Pharmacoequity in PARPi Therapy Utilization and Outcomes in Ovarian Cancer Patients: Insights From Real-World Evidence

    Jun 1, 2024, 00:00

  • MSR68 Variability and Improvements of Answers Generated with Different Versions of Large Language Models

    Jun 1, 2024, 00:00

  • HTA Decisions and Deliberative Processes

    Jun 1, 2024, 00:00

  • MSR83 Predicting Optimal Treatment Regimen to Improve Outcomes of Patients With CLL/SLL Using Random Survival Forest

    Jun 1, 2024, 00:00

  • HPR139 Examining the Intersectionality of Race, Ethnicity, and Social Vulnerabilities in Predicting Severe Maternal Morbidities Among Blue Cross and Blue Shield of Louisiana Mothers

    Jun 1, 2024, 00:00

  • RWD78 The Relationship of PROMIS Physical Function Scores, Healthcare Resource Utilization, and Charges in Patients Treated for Chronic Mechanical Low Back Pain

    Jun 1, 2024, 00:00

  • MSR67 Modelling the Patient-Level Dependence of Overall Survival on Time to Objective Response in Oncology Studies Using Copulas

    Jun 1, 2024, 00:00

  • CO8 Leading Predictors of Incident Hypertension Among Patients with Cancer in Community Health Centers: A Machine Learning Approach with Shapley Additive Explanations Using Electronic Health Records

    Jun 1, 2024, 00:00

  • PCR78 Treatment Preferences of Adult Patients With Attention-Deficit/Hyperactivity Disorder in Canada: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • HSD38 Factors Influencing Willingness To Utilize the Emergency Department Among Individuals Living With Sickle Cell Disease

    Jun 1, 2024, 00:00

  • EE499 Economic Burden of Prescription Opioid Abuse in the United States: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • HTA79 Navigating the Clinical Effectiveness Challenges for Orphan Drug Assessments: A NCPE Review

    Jun 1, 2024, 00:00

  • EE138 Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: A Conceptual Framework

    Jun 1, 2024, 00:00

  • HPR10 Cell and Gene Therapy Access in the US and European Countries

    Jun 1, 2024, 00:00

  • EPH11 Determinants of Mammography Screening Participation– A Cross-Sectional Analysis of the Hungarian Sample

    Jun 1, 2024, 00:00

  • EE251 Effect of Anticholinergic Burden on Healthcare Costs in Patients With Overactive Bladder: A Retrospective Database Claims Analysis

    Jun 1, 2024, 00:00

  • RWD111 Implementing a Pilot Chart Abstraction Period Improves the Overall Accuracy Rate in Chart Abstraction

    Jun 1, 2024, 00:00

  • EE354 Economic Burden of ICU Diseases and Injuries in Brazil During the COVID-19 Pandemic

    Jun 1, 2024, 00:00

  • EE296 A United States Payer Budget Impact Analysis of Myocardial Perfusion Imaging Modalities Positron Emission Tomography with Flurpiridaz Compared to Single Photon Emission Computed Tomography in Coronary Artery Disease Diagnosis

    Jun 1, 2024, 00:00

  • MSR6 Machine Learning Insights Into COVID-19 Variant Spread Across US Regions

    Jun 1, 2024, 00:00

  • MT11 Innovation in the Pharmaceutical Market: An Analysis of the Patents of Monoclonal Antibodies

    Jun 1, 2024, 00:00

  • MSR62 Clinical Validation of an N-Gram Model for Detecting Economic Insecurity in Patient Populations Using Unstructured Clinical Notes

    Jun 1, 2024, 00:00

  • EE22 COPD-Related Healthcare Resource Utilization Before and After Initiating Inhaled Corticosteroid-Containing Maintenance Regimens: Real World Claims Data

    Jun 1, 2024, 00:00

  • PCR79 Applying Conjoint Analysis to Explore the Preference of People in Choosing Self-Pay Health Check-up Services

    Jun 1, 2024, 00:00

  • HPR136 Geographic Trends in Chimeric Antigen Receptor (CAR) T-Cell Therapy Access and Utilization

    Jun 1, 2024, 00:00

  • EE29 Cost-Effectiveness of Niraparib Plus Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer

    Jun 1, 2024, 00:00

  • EPH134 Difference in E-Cigarette Use Prevalence in Adolescents between 2019 and 2021 in Georgia, United States

    Jun 1, 2024, 00:00

  • HTA77 PICO Consolidation in European HTA Scoping: Examining PICO Variations in Oncology Drugs in the Context of the European Joint Clinical Assessment

    Jun 1, 2024, 00:00

  • MSR65 The Benefits of a Complex Identification and Stratification Model for Depression: Insights from a Large Claims Analysis Study

    Jun 1, 2024, 00:00

  • RWD109 The Impact of the out-of-Pocket Cost of Insulin on Healthcare Resource Utilization and All Healthcare-Related Costs Using the Medical Expenditure Panel Survey 2016-2018

    Jun 1, 2024, 00:00

  • RWD137 Automated Non-Interventional Research Protocol Generation: A Case Study in Melanoma

    Jun 1, 2024, 00:00

  • EE444 Target Trial Emulation with Real-World Data to Determine the Population-Level Cost-Effectiveness of Multi-Gene Panel Sequencing for Advanced Melanoma

    Jun 1, 2024, 00:00

  • EE425 A Comparison of Payer Costs for Patients with and without Revascularization in Thoracic Endovascular Aortic Repair Stent Grafting Procedures

    Jun 1, 2024, 00:00

  • PCR179 Manifestations and Comorbid Conditions Among Patients with Osteogenesis Imperfecta (OI): A US Retrospective Claims Database Analysis

    Jun 1, 2024, 00:00

  • HPR91 Public Sector Replacement of Privately Funded Pharmaceutical RD: Cost and Efficiency Considerations

    Jun 1, 2024, 00:00

  • Health Service Delivery Process of Care

    Jun 1, 2024, 00:00

  • EE411 Cost-Effectiveness of Venetoclax in Combination with Azacitidine in Unfit Patients With Previously Untreated Acute Myeloid Leukemia in China

    Jun 1, 2024, 00:00

  • Award Winners

    Jun 1, 2024, 00:00

  • HSD99 Impact of Pink October in Mammographic Screening in a Health Care Plan in Brazil

    Jun 1, 2024, 00:00

  • PCR222 Comparison of Recanalisation Therapies in Terms of Quality of Life in Ischaemic Stroke Patients in Hungary

    Jun 1, 2024, 00:00

  • SA66 Patient Demographic and Clinical Characteristics Associated With the Use of the Newly Approved Disease-Modifying Medications for Sickle Cell Disease

    Jun 1, 2024, 00:00

  • Economic Impact of Rare Diseases

    Jun 1, 2024, 00:00

  • SA7 Outcomes With Novel Therapies for Relapsed or Refractory Follicular Lymphoma: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • EE11 Budget Impact Analysis of a Triple-Agent Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Topical Gel for the Treatment of Patients With Moderate-to-Severe Acne Vulgaris in the US

    Jun 1, 2024, 00:00

  • P38 Sources of Financial Support to Households Caring for Individuals with Duchenne Muscular Dystrophy: Results from a Caregiver Survey

    Jun 1, 2024, 00:00

  • RWD18 Healthcare Costs Associated With Type 1 Diabetes in Adults With a Commercial, Medicaid, or Medicare Coverage in US Clinical Practice

    Jun 1, 2024, 00:00

  • EPH8 Comparison of Patient Identification Methodologies in Chronic Inflammatory Demyelinating Polyneuropathy Using United States Administrative Claims Data

    Jun 1, 2024, 00:00

  • CO86 Real-World Evaluation of Intracardiac Echocardiography Guided Radio-Frequency Catheter Ablation for Atrial Fibrillation: A Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • HSD14 Characteristics of US Commercially Insured Patients with Type 2 Diabetes (T2D) Initiating Tirzepatide

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • SA39 Exploring the Landscape of Genetically Modified Natural Killer Cell (GMNKC) Therapies: A Review of Clinical Trials Indexed on ClinicalTrials.gov

    Jun 1, 2024, 00:00

  • PCR4 Enhancing Quality of Life With Self-Administered Medication Over Intravenous Infusion Treatment in a Health System Specialty Pharmacy Setting

    Jun 1, 2024, 00:00

  • RWD101 Leveraging Ways of Working and Innovation Methodologies from the Technology Sector to Inform New Approaches to Health Equity Initiatives

    Jun 1, 2024, 00:00

  • HTA54 AMNOG Benefit Assessment in Germany: Outcomes from 2011 to November 2023

    Jun 1, 2024, 00:00

  • EPH176 Comparison of Superoxide Dismutase Activities (Mn-SOD AND Cu/Zn-SOD) in Patients Infected with Dengue Virus or Zika Virus

    Jun 1, 2024, 00:00

  • EPH117 Sociodemographic Factors Associated With E-Cigarette Use Among US Adults With Diabetes, Pre-Diabetes, or Risk of Diabetes

    Jun 1, 2024, 00:00

  • EPH218 The Clinical and Economic Epidemiology of Breast Cancer in Brazil from 2016 to 2022: A Real-World Evidence Study of 295,000 Outpatients in Public System

    Jun 1, 2024, 00:00

  • RWD168 Fractures in Adults Age Eighty and Older in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • HSD112 Product Entry Sequence and Priority of Follow-on Drug Use: A Case Study of Second-Generation Antipsychotics with Long-Acting Injections

    Jun 1, 2024, 00:00

  • CO97 Trial-and-Error Treatment Leads To Delayed Disease Control of Moderate-to-Severe Rheumatoid Arthritis

    Jun 1, 2024, 00:00

  • EE393 Assessing Cost-Effectiveness in Diabetes Management: A US Healthcare Payer’s Perspective on 15MG Tirzepatide Versus 1MG Semaglutide

    Jun 1, 2024, 00:00

  • EE55 Medico-Economic Contribution of Multiplex PCR To the Diagnosis of Meningitis

    Jun 1, 2024, 00:00

  • EE168 Avoidable Costs in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated with Darolutamide

    Jun 1, 2024, 00:00

  • EE414 The Disparities in the Willingness to Pay for Health Benefits Between Prevention and Treatment Among Patients With Chronic Diseases in Saudi Arabia

    Jun 1, 2024, 00:00

  • EE60 The Excessive Burden of Low SES Caregivers: Evidence from Stroke Survivors Through CHARLS Data (2011-2018)

    Jun 1, 2024, 00:00

  • HSD76 A Systematic Literature Review (SLR) to Evaluate the Role of Socioeconomic Factors Associated with Treatment Practices Among Oncology Patients

    Jun 1, 2024, 00:00

  • EE61 Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Mexican Adults Population

    Jun 1, 2024, 00:00

  • PCR47 Characterization of Variability in Response Set Composition Across Pros: Insights for Reducing Complexity and Improving the Patient Experience of Clinical Research

    Jun 1, 2024, 00:00

  • EPH172 Humanistic and Economic Burden Among COPD Patients in China: How Does It Compare With Other Common NCDs?

    Jun 1, 2024, 00:00

  • RWD121 Mental Health Outcomes and Treatments Utilized for Postpartum Depression Patients Hospitalized for a Mood Disorder in the US Using Real-World Data

    Jun 1, 2024, 00:00

  • RWD164 Evidence Gap Analysis of the Burden of Disease in Thyroid Eye Disease

    Jun 1, 2024, 00:00

  • P18 Assessing the Value of Revascularization Strategies for Chronic Limb Threatening Ischemia in Patients with Diabetic Foot Ulcers: A Propensity Score-Weighted Evaluation

    Jun 1, 2024, 00:00

  • P19 Negative Control Outcomes (NCOs) to Assess Comparability of Psoriasis (PsO) and Psoriatic Arthritis (PsA) Treatments

    Jun 1, 2024, 00:00

  • EE21 Healthcare Resource Utilization Comparison of Balloon-Expandable Valve Versus Self-Expandable Valve for Transcatheter Aortic Valve Replacement in China

    Jun 1, 2024, 00:00

  • HPR38 Estimating the Outcome Disparities in BIPOC and Economically-Disadvantages Patients With Systemic Lupus Erythematosus (SLE)

    Jun 1, 2024, 00:00

  • EPH57 Prevalence of Hypertension Among Women Initiating a Combined Hormonal Contraception in the US

    Jun 1, 2024, 00:00

  • EE158 Economic Evaluation of Duvelisib Versus Ofatumumab in Relapsed/Refractory CLL/SLL in Japan

    Jun 1, 2024, 00:00

  • HSD122 Medication Adherence, Persistence, and Treatment Switching in Patients Receiving Advanced Therapies for Rheumatoid Arthritis in Clinical Practice

    Jun 1, 2024, 00:00

  • EPH123 Incorporating Social Determinants of Health Into Transmission Modeling of COVID-19 Vaccine in the US: A Scoping Review

    Jun 1, 2024, 00:00

  • EE502 Healthcare Resource Utilization and Cost Burden in Patients with Primary Biliary Cholangitis

    Jun 1, 2024, 00:00

  • EE38 Impact of Expenditure on Medicines for STD/AIDS on the Instituted Budget after the End of the Regime That Established a Ceiling on Public Expenditure in Brazil

    Jun 1, 2024, 00:00

  • EPH173 Estimating the Utilization of Doxycycline Post-Exposure Prophylaxis (DoxyPEP) and the Impact on Syphilis Rates in Colorado

    Jun 1, 2024, 00:00

  • EE14 Cost of Care Comparison of Elranatamab-bcmm and Teclistamab-cqyv in Adult Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

    Jun 1, 2024, 00:00

  • MSR88 The Influence of Social Determinants of Health on Healthcare Access, Utilization, and Treatments in Atopic Dermatitis Patients Using All of Us and Machine Learning Methods

    Jun 1, 2024, 00:00

  • SA51 A Non-Systematic Literature Review of Literature Reviews: Evaluation of Methods Implemented and Language Used to Describe Systematic and Non-Systematic Literature Reviews

    Jun 1, 2024, 00:00

  • EPH30 Real-World Adherence to Glycemic Self-Monitoring and Associated Factors Among Type 2 Diabetes Patients in Algeria: A Descriptive Cross-Sectional Study

    Jun 1, 2024, 00:00

  • EPH42 Evaluating the Public Health Impact of Dengue Vaccination in Indonesia: A Dynamic Transmission Modeling Assessment amidst Uncertainties in the Implementation Strategies

    Jun 1, 2024, 00:00

  • MT6 Clinical Significance of SP-D Biomarker in the Diagnosis of Connective Tissue Disease-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • EE191 Economic Evaluation of Mental Health Interventions: A Cost-Consequence Analysis

    Jun 1, 2024, 00:00

  • EE2 Challenges of Evaluating and Modelling Vaccination for Prevention of Dengue Illness in United Kingdom (UK) Travelers: A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • EE18 Burden of Illness for Adults With Chronic Inflammatory Demyelinating Polyneuropathy in the United States

    Jun 1, 2024, 00:00

  • PCR35 Impact of COVID-19 Vaccination with BNT162b2 on the Frequency of Acute Symptoms Among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy

    Jun 1, 2024, 00:00

  • EE352 Economic Burden of Prostate Cancer in the US: A Disease Stage-Based Cost Analysis

    Jun 1, 2024, 00:00

  • PT27 Changes in the Economic Burden of Breast Cancer Neoplasms in Colombia After the Cancer Control Model

    Jun 1, 2024, 00:00

  • PT45 Patient Perspective in Endometriosis and Clinical Trial Barriers

    Jun 1, 2024, 00:00

  • HSD83 Multimorbidity Patterns and Related Treatment Costs Among Middle-Aged and Older Diabetes Patients in China

    Jun 1, 2024, 00:00

  • HSD95 Utilization of Prescription Acquisition by Drive-Thru and Mail Before and During the COVID-19 Pandemic in the United States

    Jun 1, 2024, 00:00

  • CO138 Impact of Steroid Withdrawal at Various Time Points After Liver Transplantation on Diabetes Mellitus: A Population-Based Cohort Study in South Korea

    Jun 1, 2024, 00:00

  • MSR90 Incorporating Patient Preferences Into Mathematical and Statistical Models in Health Economics: A Taxonomy of Approaches

    Jun 1, 2024, 00:00

  • PCR268 Association Between Screen Time, Social Support, and Mental Health in Adolescents: Evidence From a Nationally Representative Sample in 2022

    Jun 1, 2024, 00:00

  • HPR81 Multi-Stakeholder Approach to Rare Disease Care in Latin America

    Jun 1, 2024, 00:00

  • HSD27 Patterns of Postoperative Opioid Dispensing for Common Surgical Procedures Among Medicaid Beneficiaries in 2020-2021

    Jun 1, 2024, 00:00

  • HSD30 Incidence of Platinum-Resistant, Stage III/IV Ovarian Cancer Patients in the US: A Mixed Source Estimation Approach

    Jun 1, 2024, 00:00

  • MT2 Operating Room (OR) and Sterilization Efficiencies for Total (TKA), Revision (rTKA) and Unicompartimental Knee Arthroplasty (UKA) Using a Handheld Robotic Assisted (RA) Surgical System

    Jun 1, 2024, 00:00

  • RWD20 Enhancing Oncology Model: Discordance Among Patients Using Intravenous Iron in the US

    Jun 1, 2024, 00:00

  • Methods to Include Environmental Impacts in Health Economic Evaluations and Health Technology Assessments: A Scoping Review [Editor's Choice]

    Jun 1, 2024, 00:00

  • RWD187 The Use of a Large Epidemiological Surveillance Dataset (SIVEP-Gripe) for the Generation of Scientific Evidence in Brazil on COVID-19: A Literature Review

    Jun 1, 2024, 00:00

  • PCR180 Measuring and Valuing Child Health in Canada

    Jun 1, 2024, 00:00

  • PCR217 Diagnosing Preferences to Facilitate Shared Decision-Making: Development of a Novel Preference-Based Decision Support Tool for Adult Patients with Eosinophilic Esophagitis

    Jun 1, 2024, 00:00

  • MSR78 The Impact of Variable Days of Coverage on Estimating Diagnosis and Treatment Prevalence From Administrative Claims Data

    Jun 1, 2024, 00:00

  • EPH171 A Qualitative Survey Analysis for Understanding COVID-19 Vaccine Hesitancy in the United States

    Jun 1, 2024, 00:00

  • RWD9 Anhedonia-Related Wording in Social Media: An Application of Natural Language Processing

    Jun 1, 2024, 00:00

  • EE275 Cost-Effectiveness Analysis of Biologics Used for the Treatment of Ankylosing Spondylitis in China

    Jun 1, 2024, 00:00

  • SA40 A Targeted Literature Review of Economic Evaluations, Health-Related Quality of Life, Healthcare Resource Use, and Economic Outcomes Associated With Giant Cell Arteritis

    Jun 1, 2024, 00:00

  • HTA12 Investigating the Influence of Therapy-Related Factors on Reimbursement Success: A Multi-Country Analysis

    Jun 1, 2024, 00:00

  • PCR29 Patient and Caregiver Perspectives Regarding Once-Weekly Injection Devices in Growth Hormone Deficiency: Qualitative Interviews To Inform a Patient Preference Study

    Jun 1, 2024, 00:00

  • EE283 Cost-Effectiveness Analysis of NRICM101 Compared to Usual Care for Treating COVID-19

    Jun 1, 2024, 00:00

  • MSR66 Development and Validation of Risk Prediction Tools for Pressure Injury Occurren An Umbrella Review

    Jun 1, 2024, 00:00

  • EE272 Treating Patients With Non-Valvular Atrial Fibrillation With Apixaban Provides Substantial Consumer Value and Surplus Compared With Warfarin and Rivaroxaban

    Jun 1, 2024, 00:00

  • EE27 Cost-Effectiveness of Chondroitin Sulfate Plus Glucosamine Versus Celecoxib for Moderate To Severe Knee Osteoarthritis

    Jun 1, 2024, 00:00

  • EE51 Analysis of Direct Costs of Treating Severe Hemophilia A in Brazil

    Jun 1, 2024, 00:00

  • RWD162 The Development of a National Standardset for Bariatric Surgery Followed By a Digital Solution to Scale It at a National Level in Portugal

    Jun 1, 2024, 00:00

  • EE123 Cost-Effectiveness of the Brexu-Cel in Relapsed/Refractory Mantle Cell Lymphoma and B-Cell Acute Lymphoblastic Leukemia: A Systematic Review

    Jun 1, 2024, 00:00

  • HSD4 First-Generation Antipsychotic Shortages in the United States: Analysis of Switching and Utilization Patterns

    Jun 1, 2024, 00:00

  • SA19 Mapping the Current Clinical Landscape for Alzheimer's Disease: A Qualitative Analysis

    Jun 1, 2024, 00:00

  • EE187 Remdesivir Reduced Healthcare Resource Utilization in Patients Hospitalized With COVID-19 During the Omicron-Dominant Period

    Jun 1, 2024, 00:00

  • HPR74 Challenges Encountered When Using Required Machine-Readable Files From the 2022 Transparency in Coverage Rule: A Blue Cross and Blue Shield of Louisiana Case Study

    Jun 1, 2024, 00:00

  • HSD125 Second-Line Antidiabetic Agent Order Patterns in Patients With Type 2 Diabetes Across Healthplan Types

    Jun 1, 2024, 00:00

  • Logical Inconsistencies With Expected Utility Theory May Align Better With Patient Preferences—A Response to Paulden et al

    Jun 1, 2024, 00:00

  • RWD85 An Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

    Jun 1, 2024, 00:00

  • EE234 Quality of Life and Burden of Epilepsy Patients in United States: A Comparative Study of Matched Case-Control Based on Medical Expenditure Panel Survey (MEPS), 2017-2021

    Jun 1, 2024, 00:00

  • EE321 Budget Impact Model for Dasiglucagon in the Prevention and Treatment of Hypoglycemia in Pediatric Patients with Congenital Hyperinsulinism in the United States

    Jun 1, 2024, 00:00

  • PCR135 Humanistic Burden of Fabry Disease and Associated Utility Values

    Jun 1, 2024, 00:00

  • PCR255 Evaluating the Suitability of Patients As Proxies for Caregivers’ HR-QoL Assessments

    Jun 1, 2024, 00:00

  • CO11 Captopril Response Association With Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphisms in Mexican Indigenous

    Jun 1, 2024, 00:00

  • EE13 Cost-Effectiveness Analysis of Duodenal–Jejunal Bypass Sleeve Device for People With Obesity

    Jun 1, 2024, 00:00

  • CO150 Efficiacy of Back School Program in Connection with Physical Activity Amongst Hungarian Adolescents

    Jun 1, 2024, 00:00

  • PCR218 Gender Is Not Binary: An Online Survey To Improve Inclusivity in Sex and Gender Demographic Questions

    Jun 1, 2024, 00:00

  • RWD36 Time to Reimbursement in Kazakhstan for Novel Cancer Medicines Approved during the Period 2013-2022

    Jun 1, 2024, 00:00

  • MT20 Validation of the Sensal Health Smart Dock TM Medication Adherence Device

    Jun 1, 2024, 00:00

  • MSR103 Optimizing Systematic Literature Reviews in Endometrial Cancer: Leveraging AI for Real-Time Article Screening and Data Extraction in Clinical Trials

    Jun 1, 2024, 00:00

  • Disclosure Information

    Jun 1, 2024, 00:00

  • HPR40 Do State Direct Access Laws to Physical Therapy Influence Healthcare Utilization and Costs Among Medicare Patients With Atraumatic Rotator Cuff Tears? An Instrumental Variable Approach

    Jun 1, 2024, 00:00

  • HPR11 Revenue-Sharing or Revenue Lost? The Hidden Costs of 340B to Employers

    Jun 1, 2024, 00:00

  • EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective

    Jun 1, 2024, 00:00

  • PCR211 Health-Related Quality of Life in Adult Patients With Glaucoma, With or Without Visual Impairment in the US: Analysis of National Data From 2017 to 2021

    Jun 1, 2024, 00:00

  • EPH69 Uptake of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among United States (US) Adults Following 2022 Update to Recommendations

    Jun 1, 2024, 00:00

  • EE438 A Budget Impact Model (BIM) for the Introduction of the TEARCARE® System to a United States (US) Health Plan for the Treatment of Meibomian Gland Dysfunction (MGD)-Associated Dry Eye Disease (DED)

    Jun 1, 2024, 00:00

  • PCR136 Development of a Patient Preference Questionnaire Appropriate for Use with Potential Regimens for HIV Cure

    Jun 1, 2024, 00:00

  • CO187 Acute Pancreatitis Risk Associated with Glucagon-Like Peptide-1 Receptor Agonists Used for Weight Loss: A Retrospective Cohort Study in the United States

    Jun 1, 2024, 00:00

  • EE316 Economic Burden of Fabry Disease in Colombia

    Jun 1, 2024, 00:00

  • EE242 Economic and Clinical Impact of Cost-Effective Kidney-Related Healthcare Interventions to Manage the Burden of CKD in the UK: Estimates for the Next 10 Years (2023 to 2033)

    Jun 1, 2024, 00:00

  • HPR131 The Risk of Osteoporotic Fractures in Elderly Asthmatic Patients According to Prescribing Patterns of Systemic Corticosteroid in South Korea

    Jun 1, 2024, 00:00

  • MSR24 A Case Study Using Keynote-010 to Compare and Evaluate Long-Term Survival Estimates from Two Classes of Piecewise Models

    Jun 1, 2024, 00:00

  • PCR149 Buprenorphine Adherence Trajectories, Persistence, and Healthcare Expenditures Among Commercially Insured Patients With Opioid Use Disorder

    Jun 1, 2024, 00:00

  • PCR26 Impact of Attention-Deficit/Hyperactivity Disorder Treatment Adverse Effects on Quality of Life and Functioning of Pediatric Patients and Their Parents/Caregivers

    Jun 1, 2024, 00:00

  • EPH74 Incidence and Lethality of Adult Pneumonia, Bacteremia, or Meningitis in Colombia From 2015 to 2022: A Retrospective, Database Study

    Jun 1, 2024, 00:00

  • CO73 Clinical Significance of KL-6 Biomarker in the Development of Connective Tissue Disease-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR68 Disparate Barriers to Care Among Ovarian Cancer Patients in Managing Their Sleep Disturbance and Fatigue

    Jun 1, 2024, 00:00

  • PCR145 Using Survey Data and Qualitative Interviews to Support Content Validity for Spinocerebellar Ataxia (SCA) Patients

    Jun 1, 2024, 00:00

  • P28 Impact of FDA Expedited Review Programs on New Drug Approval Time

    Jun 1, 2024, 00:00

  • EE112 Baricitinib in Alopecia Areata: A Budget Impact Analysis in Saudi Setting

    Jun 1, 2024, 00:00

  • EE509 Association between Body Mass Index and Medical Cost Among U.S. Adults in 2022

    Jun 1, 2024, 00:00

  • PCR208 The Association of Intentional Weight Reduction with Symptom Burden and PRO Measures in Patients with Obstructive Sleep Apnea: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HTA3 What Are the Reasons for Receiving a Negative Decision from NICE? - A 5-Year Review (2019-2023) of NICE Decisions

    Jun 1, 2024, 00:00

  • EE88 Cost-Effectiveness of Apixaban Compared to Warfarin, Dabigatran and Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation: Results for High-Risk Patient Subgroups Based on the Aristophanes Real-World Evidence Study

    Jun 1, 2024, 00:00

  • PCR63 Public Deliberation on Health Gain Measures

    Jun 1, 2024, 00:00

  • HTA71 Cost-effectiveness of The Top 100 Drugs By Public Spending in Canada, 2015-2021: A Repeated Cross-sectional Study

    Jun 1, 2024, 00:00

  • MT25 Smartphone-Acquired Patient Reported Outcomes and Wrist-Worn Wearable Device-Acquired Sensing Data in Rheumatoid Arthritis: A Multicenter Single-Arm Prospective Study for Digital Biomarker (INTERIM REPORT)

    Jun 1, 2024, 00:00

  • EE290 Targeted Literature Review of Cost-Effectiveness Models in Relapsed/Refractory Follicular Lymphoma

    Jun 1, 2024, 00:00

  • SA70 Identifying Early Disease Progression in Tricuspid Regurgitation When Echocardiographic Imaging Data Is Unavailable

    Jun 1, 2024, 00:00

  • EE356 Economic Burden of Diseases Caused By Overweight and Obesity in Mexico

    Jun 1, 2024, 00:00

  • HPR62 Analysis of FDA-Issued Warning Letters for Fraudulent Claims Within the Economic, Clinical, and Humanistic Outcomes (ECHO) Framework

    Jun 1, 2024, 00:00

  • HSD13 Missed Opportunities for Respiratory Disease Diagnosis in the United States During Endemic Spread of SARS-CoV-2

    Jun 1, 2024, 00:00

  • EE245 Budget Impact of Inotersen for the Treatment of Stage I or II Polyneuropathy in Adult Patients With Hereditary Transthyretin Amyloidosis (hATTR) in Public Health Mexico

    Jun 1, 2024, 00:00

  • RWD120 Evaluating the Impact of Human Growth Hormone (HGH) Drug Shortages on Patient Treatment Switching Patterns Using Real-World Data

    Jun 1, 2024, 00:00

  • PCR142 Qualitative Insights Into Disease Burden and Meaningful Change Associated With Cutaneous Neurofibromas (CNFs) in Adults With Neurofibromatosis Type 1

    Jun 1, 2024, 00:00

  • EE6 Healthcare Resource Utilization and Costs Associated With a Peptide-Based Enteral Formula With Fruit and Vegetable Ingredients: Retrospective Analysis of Children and Adults in Post-Acute Care

    Jun 1, 2024, 00:00

  • EPH20 Trends in New Prescriptions for Opioids, Non-Opioids, and Opioid Antagonists in the United States, 2019 - 2023

    Jun 1, 2024, 00:00

  • HTA26 Economic Evaluation Submitted for Reimbursement in the Brazilian Unified Health System: A Meta-Epidemiological Study

    Jun 1, 2024, 00:00

  • P26 Analyzing Drug Shortages and Pricing: Lessons from Canada

    Jun 1, 2024, 00:00

  • SA38 Adaptation of a Benefit Trade-Off Instrument to Elicit Inequality Aversion in the United States

    Jun 1, 2024, 00:00

  • RWD99 Healthcare Costs of Cancer by Clinical Stage and Cost Component in a Private Health Plan in Brazil (Real World Data)

    Jun 1, 2024, 00:00

  • EE303 Economic Costs of Informal Care for Individuals with Disabilities and Chronic Diseases in Hong Kong

    Jun 1, 2024, 00:00

  • EE46 An Early Cost-Effectiveness Analysis of Abelacimab Versus Rivaroxaban, a Standard of Care Direct Oral Anticoagulant (DOAC), in Patients with Atrial Fibrillation Using Preliminary Results from the AZALEA-TIMI 71 Trial

    Jun 1, 2024, 00:00

  • MSR31 Comparison of Indirect Cost Calculations in Chronic Diseases and Caregivers Using the 2023 US National Health and Wellness Survey

    Jun 1, 2024, 00:00

  • EE106 Cost-Effectiveness Analysis of Belimumab for the Treatment of Adults With Active Lupus Nephritis in China

    Jun 1, 2024, 00:00

  • EE249 Healthcare Utilization and Costs Associated with Remote Blood Pressure Monitoring in a US Integrated Healthcare System

    Jun 1, 2024, 00:00

  • EE71 Understanding Pharmacy Costs and the Changing Treatment Landscape in Huntington's Disease (HD) in the US: A Systematic Literature Review (SLR) and Database Review for Disease-Modifying Therapies (DMT) in Development

    Jun 1, 2024, 00:00

  • EPH124 Examining the Effect of Hypertension, Type-2 Diabetes Mellitus, Hyperlipidemia, and Obesity on Endometrial Cancer Staging

    Jun 1, 2024, 00:00

  • EE133 Burden of Illness for Adults Living With Primary Chronic Immune Thrombocytopenia in the United States

    Jun 1, 2024, 00:00

  • EE312 Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) in Pregnant Individuals for the Prevention of Respiratory Tract Disease (RTD) Caused by RSV Among Infants in Canada

    Jun 1, 2024, 00:00

  • EE327 Public Preferences for Improving Health Equity: A Qualitative Focus Group Study

    Jun 1, 2024, 00:00

  • EE495 A Targeted Literature Review of Lung Function Decline in Idiopathic Pulmonary Fibrosis to Improve Survival Predictions in Cost-Effectiveness Analyses

    Jun 1, 2024, 00:00

  • EPH241 Benzodiazepines and Adrenergic beta2-Agonists: A Synergistic Impact on Health-Related Quality of Life Among Older Adults with Prostate Cancer

    Jun 1, 2024, 00:00

  • CO62 Clinical Outcomes of Second-Line (2L) Treatments (TXS) in Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • EPH80 Outpatient Transfusions and Occurrence of Febrile Non-Hemolytic Transfusion Reactions Among U.S. Medicare Beneficiaries, Ages 65 and Older, During 2016-2022: Utility of Real-World Data

    Jun 1, 2024, 00:00

  • EPH205 Frequency of Moderate to Severe Atopic Dermatitis and Clinical Characteristics in a Colombian HMO: Results for 2015-2022

    Jun 1, 2024, 00:00

  • MSR100 Prediction Models for Cardiotoxicity Induced By Anticancer Drug in Women with Breast Cancer

    Jun 1, 2024, 00:00

  • EE378 Economic Burden of Non-Hodgkin Lymphoma Among Patients with Commercial Insurance

    Jun 1, 2024, 00:00

  • PCR250 Need for Care in Essential Tremor and the Indirect Burden on Care Partners

    Jun 1, 2024, 00:00

  • OP7 Health and Wellbeing in Teleworking: Exploring Key Factors

    Jun 1, 2024, 00:00

  • PCR92 Association of Rheumatoid Arthritis (RA) Patient Characteristics and Perceived Treatment Satisfaction, RA Impact on Life, and Task Difficulty with Promis Measures’ Physical Functioning and Upper Extremity Scores

    Jun 1, 2024, 00:00

  • HSD21 Relationships Between Census Tract-Level Social Determinants of Health and Cardiovascular Care Among Individuals Diagnosed With Breast Cancer

    Jun 1, 2024, 00:00

  • EE487 Exploring the Healthcare Resource Utilization (HCRU) Associated with Rare Diseases (RD) in the United States (US): A Systematic Literature Review (SLR) across Six Disease Areas

    Jun 1, 2024, 00:00

  • EE345 Lifetime Cost-Effectiveness of Hereditary Breast and Ovarian Cancer Prevention Based on FinnGen and Biobank Data, Data Returning Process, and Prophylaxis

    Jun 1, 2024, 00:00

  • SA10 The Safety and Effectiveness of Intraoperative Radiotherapy With Low-Energy X-Ray for Breast Cancer: A Systematic Review

    Jun 1, 2024, 00:00

  • CO94 Advancing Diabetes Care: Novel Drug Interventions in the Management and Control of Type 2 Diabetes Mellitus

    Jun 1, 2024, 00:00

  • HPR102 Trends in Specialty Pharmacy Use Among US Medicare Beneficiaries: Implications for Part D Policy

    Jun 1, 2024, 00:00

  • PCR41 Exploration on Quality of Life of Caregivers of Patients With Bipolar Affective Disorder

    Jun 1, 2024, 00:00

  • EPH224 Effectiveness of COVID-19 Vaccines in Colombia: Findings from Two Highly Specialized Healthcare Centers

    Jun 1, 2024, 00:00

  • EPH139 Adverse Events Associated with Enzyme Replacement Therapies Lysosomal Glycogen-Specific Enzyme (GAA) Medications for the Treatment of Pompe Disease

    Jun 1, 2024, 00:00

  • Quality-Adjusted Life Years, Quality-Adjusted Life-Year-Like Measures, or Neither? The Debate Continues

    Jun 1, 2024, 00:00

  • HPR144 Optimization in Universal Health Coverage Design in South Africa Considering Both Health Outcomes and Health-Induced Poverty Outcomes

    Jun 1, 2024, 00:00

  • PCR31 Crosscultural Adaptation of the Hungarian Version of Stroke Impact (SIS)

    Jun 1, 2024, 00:00

  • EE42 Value of Being the First Biosimilar Entrant

    Jun 1, 2024, 00:00

  • EPH135 Impact of Demographics and Social Determinants of Health on Hospitalization Costs in US Adults With Respiratory Syncytial Virus

    Jun 1, 2024, 00:00

  • MT30 Budget Impact of Improved Perioperative Reprocessing of Surgical Sets Used in Trauma Surgery in a Major German University Hospital

    Jun 1, 2024, 00:00

  • CO106 Clinical Outcomes of Patients in the Intensive Care Unit with Infections Caused By Multiresistant Gram-Negative Bacteria in Colombian Patients

    Jun 1, 2024, 00:00

  • EE23 Evaluation of the Relative Impact of Factors Influencing Originator U.S. Market Share Following Biosimilar Launch

    Jun 1, 2024, 00:00

  • SA37 Costs and Quality of Life in Clinical Trials of Heart Failure in the US

    Jun 1, 2024, 00:00

  • EPH219 Understanding the Impact of Physical Exercise in People Living with Myasthenia Gravis from the MGFA Global MG Patient Registry (MGFAPR) in the US (2013-2023)

    Jun 1, 2024, 00:00

  • HPR86 The Impact of Mandated Prescription Drug Monitoring Program Registration on Prescription Opioid-Related Mortality in California

    Jun 1, 2024, 00:00

  • HPR59 Do All US Payer Archetypes Consider the Same Sources of Evidence to Inform Their Drug Policies?

    Jun 1, 2024, 00:00

  • EE115 Clinical and Economic Impact of Glucagon-like Peptide-1 Agonists in Patients with Obstructive Sleep Apnea: An Exploratory Analysis

    Jun 1, 2024, 00:00

  • RWD55 Comparison of Real-World Outcomes Between a Clinical-Genomics Database and Other Real-World Databases Among Immunotherapy-Treated Patients With Advanced Non-Small Cell Lung Cancer (ANSCLC)

    Jun 1, 2024, 00:00

  • HPR44 Implications of Regulatory Telemedicine Prescribing Flexibilities on Patients With Opioid Use Disorder

    Jun 1, 2024, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10 (current)
  • »